February is not off to a good start in the USA with over 6,000 people dying of COVID-19 in the first two days
With statistics like these, what is taking the partner SI mentioned in the Edison video presentation for COVID-19 ARDS additional phase 3 trial so long to fund / start it ?
Where is the 12 month data for the first COVID-19 ARDS phase 3 trial ?
Monoclonal antibodies are now in limited use so again why is this process taking so long ?
https://www.fda.gov/news-events/pre...oclonal-antibodies-treat-covid-19-due-omicron
Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
Wed 2 Feb
Tue 1 Feb
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-139
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.105(7.64%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.49 | $1.38 | $8.181M | 5.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25443 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 60811 | 4 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |